Stromal regulation of the tumor

Nicholas J. Bernard

DOI: https://doi.org/10.1038/s41590-024-01955-1

IF: 30.5

2024-08-31

Nature Immunology

Abstract:Regulatory T (T reg ) cells provide an immunosuppressive environment in tumors, limiting the effector function of anti-tumor cells and shortening the lives of patients with cancer. Spatial analysis of where and how these cells function in the tumor environment now published in Cancer Cell shows that one mechanism of this T reg cell suppression is facilitated by so-called mregDCs (mature dendritic cells enriched in immunoregulatory molecules). Together with patient data, the researchers used a spontaneous mouse model of colorectal cancer and found perilymphatic accumulation of T reg cells in the tumor stromal tissue. RNA- and T cell receptor (TCR)-sequencing analyses indicated that these cells were highly active and clonally expanding in the tumor microenvironment and their depletion resulted in better tumor control. Further ligand–receptor and spatial data using various human cancer datasets showed that mregDCs co-localize with T reg cells in these peri-lymphatic areas. These data suggest that mregDCs release CCR4 chemoattractants that recruit T reg cells into the tumour site, where they acquire a highly immunosuppressive phenotype that can in turn inhibit the migration of tumor antigen-presenting DCs to the tumor draining lymph nodes. Whether we can therapeutically target this immunosuppressive stromal axis, however, remains to be seen. Original reference: Cancer Cell 42 , 1415–1433.e12 (2024)

immunology